相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer
W. Kong et al.
ONCOGENE (2014)
Neoadjuvant bevacizumab and anthracycline-taxane-based chemotherapy in 678 triple-negative primary breast cancers; results from the geparquinto study (GBG 44)
B. Gerber et al.
ANNALS OF ONCOLOGY (2013)
Differential Distribution of microRNAs in Breast Cancer Grouped by Clinicopathological Subtypes
Jian-Yi Li et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
Overexpressions of MicroRNA-9 and MicroRNA-200c in Human Breast Cancers Are Associated with Lymph Node Metastasis
Jincai Wang et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2013)
AC1MMYR2, an Inhibitor of Dicer-Mediated Biogenesis of Oncomir miR-21, Reverses Epithelial-Mesenchymal Transition and Suppresses Tumor Growth and Progression
Zhendong Shi et al.
CANCER RESEARCH (2013)
Oncogenic miR-181a/b afect the DNA damage response in aggressive breast cancer
Andrea Bisso et al.
CELL CYCLE (2013)
MicroRNA-31 Sensitizes Human Breast Cells to Apoptosis by Direct Targeting of Protein Kinase C ε (PKCε)
Cindy Koerner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
miR-200c enhances radiosensitivity of human breast cancer cells
Jing Lin et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2013)
TGF-beta upregulates miR-181a expression to promote breast cancer metastasis
Molly A. Taylor et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Randomized Phase II Study of the Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Cetuximab With Cisplatin Versus Cisplatin Alone in Patients With Metastatic Triple-Negative Breast Cancer
Jose Baselga et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
The shaping and functional consequences of the microRNA landscape in breast cancer
Heidi Dvinge et al.
NATURE (2013)
MiR-130a, miR-203 and miR-205 jointly repress key oncogenic pathways and are downregulated in prostate carcinoma
K. Boll et al.
ONCOGENE (2013)
Integrated MicroRNA and mRNA Signatures Associated with Survival in Triple Negative Breast Cancer
Luciano Cascione et al.
PLOS ONE (2013)
Expression and regulatory function of miRNA-182 in triple-negative breast cancer cells through its targeting of profilin 1
Hailing Liu et al.
TUMOR BIOLOGY (2013)
Expression Analysis of MiR-21, MiR-205, and MiR-342 in Breast Cancer in Iran
Shahram Savad et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2012)
Common genetic polymorphisms of microRNA biogenesis pathway genes and breast cancer survival
Hyuna Sung et al.
BMC CANCER (2012)
MicroRNA-regulated gene networks during mammary cell differentiation are associated with breast cancer
Eylem Aydogdu et al.
CARCINOGENESIS (2012)
KRAS alleles The LCS6 3'UTR variant and KRAS coding sequence mutations in the NCI-60 panel
Samrat T. Kundu et al.
CELL CYCLE (2012)
MiR-34b is associated with clinical outcome in triple-negative breast cancer patients
Marek Svoboda et al.
DIAGNOSTIC PATHOLOGY (2012)
Genetic Variants in the MicroRNA Machinery Gene GEMIN4 Are Associated with Risk of Prostate Cancer: A Case-control Study of the Chinese Han Population
Jiaming Liu et al.
DNA AND CELL BIOLOGY (2012)
MicroRNA-203 leads to G1 phase cell cycle arrest in laryngeal carcinoma cells by directly targeting survivin
Ka Bian et al.
FEBS LETTERS (2012)
High Expression of MicroRNA-210 is an Independent Factor Indicating a Poor Prognosis in Japanese Triple-negative Breast Cancer Patients
Tatsuya Toyama et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2012)
First-Line Treatment of Advanced Breast Cancer With Sunitinib in Combination With Docetaxel Versus Docetaxel Alone: Results of a Prospective, Randomized Phase III Study
Jonas Bergh et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
Gunter von Minckwitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Expression of Dicer and Drosha in triple-negative breast cancer
Nadia Passon et al.
JOURNAL OF CLINICAL PATHOLOGY (2012)
Meta-analysis of human lung cancer microRNA expression profiling studies comparing cancer tissues with normal tissues
Peng Guan et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2012)
MicroRNA-203 suppresses cell proliferation and migration by targeting BIRC5 and LASP1 in human triple-negative breast cancer cells
Chen Wang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2012)
MiR-182 overexpression in tumourigenesis of high-grade serous ovarian carcinoma
Zhaojian Liu et al.
JOURNAL OF PATHOLOGY (2012)
miR-31 and its host gene lncRNA LOC554202 are regulated by promoter hypermethylation in triple-negative breast cancer
Katarzyna Augoff et al.
MOLECULAR CANCER (2012)
Garcinol Regulates EMT and Wnt Signaling Pathways In Vitro and In Vivo, Leading to Anticancer Activity against Breast Cancer Cells
Aamir Ahmad et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Oncosuppressive role of p53-induced miR-205 in triple negative breast cancer
Claudia Piovan et al.
MOLECULAR ONCOLOGY (2012)
Down-regulation of microRNA-200c is associated with drug resistance in human breast cancer
Junqing Chen et al.
MEDICAL ONCOLOGY (2012)
Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer
Harry D. Bear et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Genetic Variations in Key MicroRNA Processing Genes and Risk of Head and Neck Cancer: A Case-Control Study in Chinese Population
Hongxia Ma et al.
PLOS ONE (2012)
miR-200c Targets a NF-κB Up-Regulated TrkB/NTF3 Autocrine Signaling Loop to Enhance Anoikis Sensitivity in Triple Negative Breast Cancer
Erin N. Howe et al.
PLOS ONE (2012)
MicroRNA-200 Family Modulation in Distinct Breast Cancer Phenotypes
Maria Angeles Castilla et al.
PLOS ONE (2012)
Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA
Stefano Volinia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
miR-34 – a microRNA replacement therapy is headed to the clinic
Andreas G. Bader
Frontiers in Genetics (2012)
Identification of the receptor tyrosine kinase AXL in breast cancer as a target for the human miR-34a microRNA
Mark Mackiewicz et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
MicroRNA Sequence and Expression Analysis in Breast Tumors by Deep Sequencing
Thalia A. Farazi et al.
CANCER RESEARCH (2011)
microRNA-Associated Progression Pathways and Potential Therapeutic Targets Identified by Integrated mRNA and microRNA Expression Profiling in Breast Cancer
Francesca M. Buffa et al.
CANCER RESEARCH (2011)
Lin28A and Lin28B Inhibit let-7 MicroRNA Biogenesis by Distinct Mechanisms
Elena Piskounova et al.
CELL (2011)
MicroRNA expression analysis in triple-negative (ER, PR and Her2/neu) breast cancer
Jelena Radojicic et al.
CELL CYCLE (2011)
Survivin As a Predictive Biomarker of Complete Pathologic Response to Neoadjuvant Chemotherapy in Patients With Stage II and Stage III Breast Cancer
Cristiane Rios Petrarca et al.
CLINICAL BREAST CANCER (2011)
Down-regulation of BRCA1 expression by miR-146a and miR-146b-5p in triple negative sporadic breast cancers
Amandine I. Garcia et al.
EMBO MOLECULAR MEDICINE (2011)
Down-regulation of the miRNA master regulators Drosha and Dicer is associated with specific subgroups of breast cancer
Konstantin J. Dedes et al.
EUROPEAN JOURNAL OF CANCER (2011)
Developing therapeutic microRNAs for cancer
A. G. Bader et al.
GENE THERAPY (2011)
WAVE3, an actin remodeling protein, is regulated by the metastasis suppressor microRNA, miR-31, during the invasion-metastasis cascade
Khalid Sossey-Alaoui et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Brian D. Lehmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Alternative miRNA Biogenesis Pathways and the Interpretation of Core miRNA Pathway Mutants
Jr-Shiuan Yang et al.
MOLECULAR CELL (2011)
A 3′-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysis
Trupti Paranjape et al.
LANCET ONCOLOGY (2011)
Systemic Delivery of Tumor Suppressor microRNA Mimics Using a Neutral Lipid Emulsion Inhibits Lung Tumors in Mice
Phong Trang et al.
MOLECULAR THERAPY (2011)
Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155
Suhwan Chang et al.
NATURE MEDICINE (2011)
Zeb1 is required for TrkB-induced epithelial-mesenchymal transition, anoikis resistance and metastasis
M. A. Smit et al.
ONCOGENE (2011)
Molecular Stratification of Triple-Negative Breast Cancers
Charles M. Perou
ONCOLOGIST (2011)
Cell-free nucleic acids as biomarkers in cancer patients
Heidi Schwarzenbach et al.
NATURE REVIEWS CANCER (2011)
Targets of miR-200c mediate suppression of cell motility and anoikis resistance
Erin N. Howe et al.
BREAST CANCER RESEARCH (2011)
microRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival
Simona Rossi et al.
BLOOD (2010)
Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer
Carlos H. Barrios et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
miR-181a and miR-630 Regulate Cisplatin-Induced Cancer Cell Death
Lorenzo Galluzzi et al.
CANCER RESEARCH (2010)
Genetic Variants in MicroRNA Biosynthesis Pathways and Binding Sites Modify Ovarian Cancer Risk, Survival, and Treatment Response
Dong Liang et al.
CANCER RESEARCH (2010)
The Promise of MicroRNA Replacement Therapy
Andreas G. Bader et al.
CANCER RESEARCH (2010)
miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma
Mayuko Furuta et al.
CARCINOGENESIS (2010)
Lin-28B expression promotes transformation and invasion in human hepatocellular carcinoma
Yun-Chu Wang et al.
CARCINOGENESIS (2010)
Genetic variations in microRNA-related genes are associated with survival and recurrence in patients with renal cell carcinoma
Jie Lin et al.
CARCINOGENESIS (2010)
MicroRNA-related genetic variations as predictors for risk of second primary tumor and/or recurrence in patients with early-stage head and neck cancer
Xiaofan Zhang et al.
CARCINOGENESIS (2010)
A MicroRNA Targeting Dicer for Metastasis Control
Graziano Martello et al.
CELL (2010)
Microrna let-7: an emerging next-generation cancer therapeutic
D. Barh et al.
Current Oncology (2010)
The role of let-7 in cell differentiation and cancer
Benjamin Boyerinas et al.
ENDOCRINE-RELATED CANCER (2010)
Canonical and alternate functions of the microRNA biogenesis machinery
Mark M. W. Chong et al.
GENES & DEVELOPMENT (2010)
Survival prediction of gastric cancer by a seven-microRNA signature
Xiaohua Li et al.
GUT (2010)
Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers
Lei Yu et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Prognostic impact of microRNA-related gene polymorphisms on survival of patients with colorectal cancer
Hyun-Chul Lee et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
MicroRNA Expression Profiles Associated with Mutational Status and Survival in Malignant Melanoma
Stefano Caramuta et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Epithelial Mesenchymal Transition Traits in Human Breast Cancer Cell Lines Parallel the CD44hi/CD24lo/- Stem Cell Phenotype in Human Breast Cancer
Tony Blick et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2010)
Biologic profiling of lymph node negative breast cancers by means of microRNA expression
Emiel A. M. Janssen et al.
MODERN PATHOLOGY (2010)
OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma
Pedro P. Medina et al.
NATURE (2010)
A Dicer-independent miRNA biogenesis pathway that requires Ago catalysis
Sihem Cheloufi et al.
NATURE (2010)
Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model
Li Ma et al.
NATURE BIOTECHNOLOGY (2010)
Exosomes from human saliva as a source of microRNA biomarkers
A. Michael et al.
ORAL DISEASES (2010)
miR-24 Regulates Apoptosis by Targeting the Open Reading Frame (ORF) Region of FAF1 in Cancer Cells
Wenming Qin et al.
PLOS ONE (2010)
A Novel miRNA Processing Pathway Independent of Dicer Requires Argonaute2 Catalytic Activity
Daniel Cifuentes et al.
SCIENCE (2010)
A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer
Merle Hanke et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2010)
Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies
Fiona M. Blows et al.
PLOS MEDICINE (2010)
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
Aleix Prat et al.
BREAST CANCER RESEARCH (2010)
High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-β1
Biyun Qian et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
microRNA-205 Regulates HER3 in Human Breast Cancer
Marilena V. Iorio et al.
CANCER RESEARCH (2009)
被撤回的出版物: A Pleiotropically Acting MicroRNA, miR-31, Inhibits Breast Cancer Metastasis (Retracted article. See vol. 161, pg. 417, 2015)
Scott Valastyan et al.
CELL (2009)
Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells
Yohei Shimono et al.
CELL (2009)
MiR-34, SIRT1 and p53 The feedback loop
Munekazu Yamakuchi et al.
CELL CYCLE (2009)
Suppression of cell growth and invasion by miR-205 in breast cancer
Hailong Wu et al.
CELL RESEARCH (2009)
Molecular Characterization of Breast Cancer with High-Resolution Oligonucleotide Comparative Genomic Hybridization Array
Fabrice Andre et al.
CLINICAL CANCER RESEARCH (2009)
Salivary microRNA: Discovery, Characterization, and Clinical Utility for Oral Cancer Detection
Noh Jin Park et al.
CLINICAL CANCER RESEARCH (2009)
Triple-negative and HER2-overexpressing breast cancers exhibit an elevated risk and an earlier occurrence of cerebral metastases
Florian Heitz et al.
EUROPEAN JOURNAL OF CANCER (2009)
Pluripotent factor lin-28 and its homologue lin-28b in epithelial ovarian cancer and their associations with disease outcomes and expression of let-7a and IGF-II
Lingeng Lu et al.
EUROPEAN JOURNAL OF CANCER (2009)
A Twist-Snail Axis Critical for TrkB-Induced Epithelial-Mesenchymal Transition-Like Transformation, Anoikis Resistance, and Metastasis
Marjon A. Smit et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Genetic Alterations and Oncogenic Pathways Associated with Breast Cancer Subtypes
Xiaolan Hu et al.
MOLECULAR CANCER RESEARCH (2009)
Lin28 promotes transformation and is associated with advanced human malignancies
Srinivas R. Viswanathan et al.
NATURE GENETICS (2009)
Deadenylation is a widespread effect of miRNA regulation
Ana Eulalio et al.
RNA (2009)
Gene expression in murine mammary epithelial stem cell-like cells shows similarities to human breast cancer gene expression
Cecilia Williams et al.
BREAST CANCER RESEARCH (2009)
MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer
Aoife J. Lowery et al.
BREAST CANCER RESEARCH (2009)
A SNP in a let-7 microRNA Complementary Site in the KRAS 3′ Untranslated Region Increases Non-Small Cell Lung Cancer Risk
Lena J. Chin et al.
CANCER RESEARCH (2008)
Evaluation of genetic variants in microRNA-related genes and risk of bladder cancer
Hushan Yang et al.
CANCER RESEARCH (2008)
MicroRNAs as regulators of epithelial-mesenchymal transition
Philip. A. Gregory et al.
CELL CYCLE (2008)
MicroRNA-21 targets tumor suppressor genes in invasion and metastasis
Shuomin Zhu et al.
CELL RESEARCH (2008)
A Phase II Trial of Erlotinib in Combination with Bevacizumab in Patients with Metastatic Breast Cancer
Maura N. Dickler et al.
CLINICAL CANCER RESEARCH (2008)
A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells
Ulrike Burk et al.
EMBO REPORTS (2008)
Intron-mediated RNA interference and microRNA (miRNA)
Shi-Lung Lin et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
被撤回的出版物: MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer (Retracted article. See vol. 175, pg. 192, 2023)
Douglas D. Taylor et al.
GYNECOLOGIC ONCOLOGY (2008)
How basal are triple-negative breast cancers?
Francois Bertucci et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma
Aaron J. Schetter et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2
Manav Korpal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane
Harold J. Burstein et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer
Cornelia Liedtke et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
MicroRNA-21 is Overexpressed in Pancreatic Cancer and a Potential Predictor of Survival
Mary Dillhoff et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2008)
Endogenous human microRNAs that suppress breast cancer metastasis
Sohail F. Tavazoie et al.
NATURE (2008)
The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis
Qihong Huang et al.
NATURE CELL BIOLOGY (2008)
A search for conserved sequences in coding regions reveals that the let-7 microRNA targets Dicer within its coding sequence
Joshua J. Forman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
MicroRNA-373 induces expression of genes with complementary promoter sequences
Robert F. Place et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Circulating microRNAs as stable blood-based markers for cancer detection
Patrick S. Mitchell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis
Li-Xu Yan et al.
RNA (2008)
let-7 microRNAs in development, stem cells and cancer
Ingo Buessing et al.
TRENDS IN MOLECULAR MEDICINE (2008)
Altered microRNA expression confined to specific epithelial cell Subpopulations in breast cancer
Lorenzo F. Sempere et al.
CANCER RESEARCH (2007)
Iet-7 regulates self renewal and tumorigenicity of breast cancer cells
Fengyan Yu et al.
CELL (2007)
American society of clinical oncology 2007 update of recommendations for the use of tumor markers in breast cancer
Lyndsay Harris et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
[Anonymous]
JOURNAL OF ONCOLOGY PRACTICE (2007)
Tumour invasion and metastasis initiated by microRNA 10b in breast cancer
Li Ma et al.
NATURE (2007)
MicroRNA signatures in human ovarian cancer
Marilena V. Iorio et al.
CANCER RESEARCH (2007)
Intronic microRNA precursors that bypass Drosha processing
J. Graham Ruby et al.
NATURE (2007)
A hexanucleotide element directs microRNA nuclear import
Hun-Way Hwang et al.
SCIENCE (2007)
MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype
Cherie Blenkiron et al.
GENOME BIOLOGY (2007)
An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer
Andrew E. Teschendorff et al.
GENOME BIOLOGY (2007)
Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells
Hadi Valadi et al.
NATURE CELL BIOLOGY (2007)
Small dsRNAs induce transcriptional activation in human cells
Long-Cheng Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies
Michael D. Mattie et al.
MOLECULAR CANCER (2006)
Silencing of LASP-1 influences zyxin localization, inhibits proliferation and reduces migration in breast cancer cells
TGP Grunewald et al.
EXPERIMENTAL CELL RESEARCH (2006)
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis
N Yanaihara et al.
CANCER CELL (2006)
Dicing and slicing - The core machinery of the RNA interference pathway
SM Hammond
FEBS LETTERS (2005)
Prospective multicenter validation of the independent prognostic value of the mitotic activity index in lymph node-negative breast cancer patients younger than 55 years
JPA Baak et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
MicroRNA gene expression deregulation in human breast cancer
MV Iorio et al.
CANCER RESEARCH (2005)
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma
TO Nielsen et al.
CLINICAL CANCER RESEARCH (2004)
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
S Paik et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
MicroRNA genes are transcribed by RNA polymerase II
Y Lee et al.
EMBO JOURNAL (2004)
Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs
R Yi et al.
GENES & DEVELOPMENT (2003)
Prognostic importance of survivin in breast cancer
SM Kennedy et al.
BRITISH JOURNAL OF CANCER (2003)
A gene-expression signature as a predictor of survival in breast cancer.
MJ van de Vijver et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Gene expression profiling predicts clinical outcome of breast cancer
LJ van't Veer et al.
NATURE (2002)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
分享论文
